|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Extragonadal Germ Cell Tumor | |||||
| Teratoma | |||||
| Testicular Germ Cell Tumor | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Neoplasms, Germ Cell and Embryonal | |||||
| 3 | More general conditions related to this trial | ||||
| Neoplasms | |||||
| Neoplasms by Histologic Type | |||||
| 4 | Interventions listed in this trial | ||||
| bleomycin | |||||
| cisplatin | |||||
| etoposide | |||||
| filgrastim | |||||
| paclitaxel | |||||
| 5 | More general drug interventions related to this trial | ||||
| Antimitotic Agents | |||||
| Antineoplastic Agents | |||||
| Antineoplastic Agents, Phytogenic | |||||
| Mitosis Modulators | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Therapeutic Uses | |||||
| Tubulin Modulators | |||||
| 6 | Sponsors listed in this trial | ||||
| European Organization for Research and Treatment of Cancer | |||||